The new regulatory approvals expand Medtronic’s mapping and tissue-proximity capabilities for cardiac ablation.
Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced regulatory milestones for software used with two cardiac ablation platforms. This includes U.S. Food and Drug ...
Analysis of cell-ablated organisms can uncover the roles of specific tissues, or tissue interactions, during development and homeostasis. In addition, analysis of recovery after ablation may reveal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results